Lexaria Bioscience Corp. — Director's Dealing 2018

May 31, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Lexaria Bioscience Corp. (LXRP)
CIK: 0001348362
Period of Report: 2010-01-20

Reporting Person: BUNKA CHRISTOPHER (Director, CEO, 10% Owner)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-05-31	Stock Options	$1.53	A	700000	Acquired	2023-05-31	Common Shares (700000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Shares	5631844	Indirect
Common Shares	7265054	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Options	$0.1	2019-12-23	Common Shares (550000)	550000	Direct
Stock Options	$0.09	2018-06-18	Common Shares (247500)	797500	Direct
Warrants	$0.14	2018-08-11	Common Shares (450000)	450000	Indirect